Immunotherapy Promising in Parkinson’s Disease – Medscape
Medscape |
Immunotherapy Promising in Parkinson's Disease
Medscape VANCOUVER — Immunotherapy using a novel monoclonal antibody appears to be a promising new approach to treating Parkinson's disease (PD). A phase 1b study of a humanized IgG1 monoclonal antibody directed against α-synuclein (PRX002, … |
